10 results
S-3ASR
EX-1.2
APGE
Apogee Therapeutics, Inc.
12 Aug 24
Automatic shelf registration
5:25pm
, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws
10-K
2023 FY
APGE
Apogee Therapeutics, Inc.
5 Mar 24
Annual report
6:15am
in the impairment of the skin barrier in AD, which leads to transepidermal water loss and susceptibility to irritants and allergens, creating an inflammatory
DRS
APGE
Apogee Therapeutics, Inc.
9 Feb 24
Draft registration statement
12:00am
with Th2 response and IL-4 and IL-13 play a key role in the impairment of the skin barrier in AD, which leads to transepidermal water loss
424B4
APGE
Apogee Therapeutics, Inc.
17 Jul 23
Prospectus supplement with pricing info
4:08pm
play a key role in the impairment of the skin barrier in AD, which leads to transepidermal water loss and susceptibility to irritants and allergens
S-1
exibmmlvs5
22 Jun 23
IPO registration
4:19pm
DRS/A
jlxdhhdaisdyhgw oz
5 Jun 23
Draft registration statement (amended)
12:00am
DRS
jv3hou
28 Apr 23
Draft registration statement
12:00am
- Prev
- 1
- Next